Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Z41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,475
Award facts
- Contract value 100% obligated
- $12,475.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 21, 2026, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a contract value of $12,475.49 and an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is the location of AmerisourceBergen's corporate headquarters. DESCOVY is an antiretroviral medication used in the treatment and prevention of HIV, reflecting the Defense Logistics Agency's responsibility for supplying pharmaceutical products to military healthcare systems and federal medical institutions.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally and serve customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F9Z41?
SPE2DR26F9Z41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9Z41 worth?
The government has obligated $12,475 on SPE2DR26F9Z41.
Is contract SPE2DR26F9Z41 an order under another contract?
Yes. SPE2DR26F9Z41 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Z41 competed?
The extent of competition for SPE2DR26F9Z41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award